NutriLeads attracts Series B funding to launch its innovative immune-enhancing ingredient, Xtramune™, and to progress its portfolio of health ingredients
3 September, 2020 Dutch Health Ingredients company, NUTRILEADS BV, announces the closing of a Series B financing round of 6.5 m€, led by ICOS CAPITAL together with GOEIE-GRUTTEN and existing shareholders DSM VENTURING, OOST NL, SHIFT INVEST and THUJA. NutriLeads, established in 2012, develops innovative natural food ingredients with clinically proven health benefits for application […]
Jan Jongsma joined NutriLeads as VP Supply Chain & Operations
/in News /by Annette van NieuwkoopWith effect from 16 November 2020 Jan Jongsma joined NutriLeads as VP Supply Chain & Operations. He has a broad experience in the global B-t-B Food and Pharma supply industries. And was active in senior management and executive roles in sourcing & trade, production, logistics, plant investment and procurement. For many years he has worked at FrieslandCampina […]
Publication of scientific results on gut microbiome modulation
/in News /by Annette van NieuwkoopOne of NutriLeads’ health ingredients derived from carrot fibre, i.e. cRG-I, has been assessed for its prebiotic properties using an original combination of in vitro models that mimic parts of the human intestinal tract and the promising results have been published in a peer-reviewed scientific journal (Van den Abbeele et al, Nutrients 2020, 12(7), 1917; https://doi.org/10.3390/nu12071917). As expected […]
Changes NutriLeads’ Supervisory Board
/in News /by Annette van NieuwkoopFollowing the closing of Series B the composition of Nutrileads’ Supervisory Board has been changed. After nearly 5 years, Rudy Mareel stepped down as Chairman of the Board and Sanne Melles was selected as new Chairman. Nityen Lal joined the existing Board members, Florentine Fockema Andreae, Michel Briejer and Rob Beudeker who all remain in […]
Self-affirmed General Recognition of Safety for Xtramune™
/in News /by Annette van NieuwkoopNutriLeads has received positive feedback from an independent panel of experts that assessed the safety of its unique carrot-derived fiber that is specifically enriched for the rhamnogalacturonan-I pectin fraction, branded Xtramune™. It is NutriLeads’ first health ingredient planned for commercialization. The expertpanel concluded that the dossier, which reviews and summarizes all the available scientific evidence […]
NutriLeads attracts Series B funding to launch its innovative immune-enhancing ingredient, Xtramune™, and to progress its portfolio of health ingredients
/in News, Press Releases /by Annette van Nieuwkoop3 September, 2020 Dutch Health Ingredients company, NUTRILEADS BV, announces the closing of a Series B financing round of 6.5 m€, led by ICOS CAPITAL together with GOEIE-GRUTTEN and existing shareholders DSM VENTURING, OOST NL, SHIFT INVEST and THUJA. NutriLeads, established in 2012, develops innovative natural food ingredients with clinically proven health benefits for application […]